Financial Services -
Financial - Capital Markets - NYSE - US
$ 213.36
-1.68 %
$ 3.78 B
Market Cap
20.84
P/E
1. INTRINSIC VALUE
Balance Sheet
Piper Sandler Companies
| Current Assets | 834 M |
| Cash & Short-Term Investments | 483 M |
| Receivables | 272 M |
| Other Current Assets | 79.5 M |
| Non-Current Assets | 707 M |
| Long-Term Investments | 0 |
| PP&E | 126 M |
| Other Non-Current Assets | 581 M |
| Current Liabilities | 15.9 M |
| Accounts Payable | 5.86 M |
| Short-Term Debt | 10 M |
| Other Current Liabilities | 0 |
| Non-Current Liabilities | 88.8 M |
| Long-Term Debt | 88.8 M |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
Piper Sandler Companies
| Revenue | 1.53 B |
| Cost Of Revenue | 1 B |
| Gross Profit | 527 M |
| Operating Expenses | 42.2 M |
| Operating Income | 485 M |
| Other Expenses | 328 M |
| Net Income | 157 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Piper Sandler Companies
| Net Income | 157 M |
| Depreciation & Amortization | 27.1 M |
| Capital Expenditures | -15.5 M |
| Stock-Based Compensation | 103 M |
| Change in Working Capital | -8.88 M |
| Others | 7.76 M |
| Free Cash Flow | 298 M |
Wall Street Analysts Price Targets
Piper Sandler Companies
Wall Street analysts predict an average 1-year price target for PIPR of $182 , with forecasts ranging from
a
low of
$55 to a high of $292 .
PIPR Lowest Price Target
Wall Street Target
55 USD
-74.22%
PIPR Average Price Target
Wall Street Target
182 USD
-14.93%
PIPR Highest Price Target
Wall Street Target
292 USD
36.86%
4. DIVIDEND
ANALYSIS
0.27%
DIVIDEND YIELD
3.65 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Piper Sandler Companies
Sold
0-3 MONTHS
5.25 M USD 2
3-6 MONTHS
3.86 M USD 2
6-9 MONTHS
6.72 M USD 4
9-12 MONTHS
1.39 M USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Piper Sandler Expands Healthcare Investment Banking Team with the Addition of Christian Draisbach
NEW YORK--(BUSINESS WIRE)---- $PIPR--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Christian Draisbach as a managing director to the healthcare investment banking team. Draisbach will be responsible for advising and supporting clients in the biopharma sector. “We are excited for Christian to join our healthcare investment banking team. Christian brings 20 years of experience advising biopharma executives and boards through the lifecycle of their b.
businesswire.com
- 3 days ago
Quaker Houghton price target lowered to $120 from $140 at Piper Sandler
Piper Sandler lowered the firm's price target on Quaker Houghton to $120 from $140 and keeps a Neutral rating on the shares. The tariffs instituted by the U.S. and the likely retaliation and peripheral economic fallout from those tariffs have the potential to create long-lasting complications for the U.S. chemical industry, which is built on the significant advantage of ethane-based chemical production and exports as a means of growing volume and revenues in an otherwise low-growth U.S. market. Piper cautions that retaliation will likely ultimately not be helpful for foreign producers either.
https://thefly.com
- 3 days ago
Eastman Chemical price target lowered to $99 from $105 at Piper Sandler
Piper Sandler lowered the firm's price target on Eastman Chemical to $99 from $105 and keeps a Neutral rating on the shares. The tariffs instituted by the U.S. and the likely retaliation and peripheral economic fallout from those tariffs have the potential to create long-lasting complications for the U.S. chemical industry, which is built on the significant advantage of ethane-based chemical production and exports as a means of growing volume and revenues in an otherwise low-growth U.S. market. Piper cautions that retaliation will likely ultimately not be helpful for foreign producers either.
https://thefly.com
- 3 days ago
Dow Inc. price target lowered to $37 from $46 at Piper Sandler
Piper Sandler lowered the firm's price target on Dow Inc. to $37 from $46 and keeps a Neutral rating on the shares. The tariffs instituted by the U.S. and the likely retaliation and peripheral economic fallout from those tariffs have the potential to create long-lasting complications for the U.S. chemical industry, which is built on the significant advantage of ethane-based chemical production and exports as a means of growing volume and revenues in an otherwise low-growth U.S. market. Piper cautions that retaliation will likely ultimately not be helpful for foreign producers either. 10 Apr 24 Apr
https://thefly.com
- 3 days ago
Celanese price target lowered to $48 from $50 at Piper Sandler
Piper Sandler analyst Charles Neivert lowered the firm's price target on Celanese to $48 from $50 and keeps an Underweight rating on the shares. The tariffs instituted by the U.S. and the likely retaliation and peripheral economic fallout from those tariffs have the potential to create long-lasting complications for the U.S. chemical industry, which is built on the significant advantage of ethane-based chemical production and exports as a means of growing volume and revenues in an otherwise low-growth U.S. market. Piper cautions that retaliation will likely ultimately not be helpful for foreign producers either. 06 May 14 May
https://thefly.com
- 3 days ago
Piper Sandler Expands Research Distribution with New Office Opening in Zurich
ZURICH--(BUSINESS WIRE)---- $PIPR--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is excited to announce a new office opening in Zurich, Switzerland led by experienced industry veterans, Alex Molloy, Vincenzo Pescuma and Luigi Colazzo, who will manage the sales and distribution of Piper Sandler's U.S. equity research and trading products to Swiss based clients. All three were previously at Credit Suisse. “The European market is a tremendous opportunity for the firm, and we are thrilled.
businesswire.com
- 1 month ago
Piper Sandler Strengthens Fixed Income Team with the Addition of Mary Stone
NEW YORK--(BUSINESS WIRE)---- $PIPR--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Mary Stone as a managing director and co-head of the structured finance group alongside Chris Howley. She will be based in the New York office. “We are ecstatic to have Mary on the Piper Sandler platform. Mary's deep expertise within multiple securitization markets, whole loan trading, and deal structuring will immediately benefit our clients,” said Mike Piper, mana.
businesswire.com
- 1 month ago
Piper Sandler Offers Stockholders a New Share Buyback Program
PIPR announces a new share repurchase program. Given the strong balance sheet and liquidity position, such capital distributions seem sustainable.
zacks.com
- 2 months ago
Piper Sandler Companies Announces Share Repurchase Authorization
MINNEAPOLIS--(BUSINESS WIRE)---- $PIPR--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that its board of directors has authorized the repurchase of up to $150 million of the company's outstanding common stock. This authorization is effective immediately and will expire on December 31, 2026. The share repurchase program will be used as part of the company's capital allocation strategy, which includes returning capital to its shareholders, and to offset the dilutive effect.
businesswire.com
- 2 months ago
Piper Sandler Companies (PIPR) Upgraded to Strong Buy: Here's Why
Piper Sandler Companies (PIPR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
zacks.com
- 2 months ago
Piper Sandler Companies (PIPR) Q4 2024 Earnings Call Transcript
Piper Sandler Companies (PIPR) Q4 2024 Earnings Call Transcript
seekingalpha.com
- 2 months ago
Piper Sandler Companies (PIPR) Q4 Earnings and Revenues Beat Estimates
Piper Sandler Companies (PIPR) came out with quarterly earnings of $4.80 per share, beating the Zacks Consensus Estimate of $3.62 per share. This compares to earnings of $4.03 per share a year ago.
zacks.com
- 2 months ago
8. Profile
Summary
Piper Sandler Companies PIPR
COUNTRY
US
INDUSTRY
Financial - Capital Markets
MARKET CAP
$ 3.78 B
Dividend Yield
0.27%
Description
Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States and internationally. The company offers investment banking and institutional sales, trading, and research services for various equity and fixed income products. It provides advisory services, such as mergers and acquisitions, equity private placements, and debt and restructuring advisory; raises capital through equity and debt financings; underwrites municipal issuances; and offers municipal financial advisory and loan placement services, as well as various over-the-counter derivative products. The company also offers public finance investment banking services that focus on state and local governments, and cultural and social service non-profit entities, as well as the education, healthcare, hospitality, senior living, and transportation sectors. In addition, it provides equity and fixed income advisory and trade execution services for institutional investors, and government and non-profit entities. Further, the company is involved in the alternative asset management funds merchant banking and healthcare to invest firm capital and to manage capital from outside investors, as well as trading activities. The company was formerly known as Piper Jaffray Companies and changed its name to Piper Sandler Companies in January 2020. Piper Sandler Companies was founded in 1895 and is headquartered in Minneapolis, Minnesota.
Contact
800 Nicollet Mall, Minneapolis, MN, 55402
https://www.pipersandler.com
IPO
Date
Jan. 2, 2004
Employees
1805
Officers
Ms. Debbra Lynn Schoneman
President
Mr. Jonathan Jay Doyle
Senior Managing Principal, Head of Financial Services Group & Vice Chairman
Mr. Michael Jared Kantrowitz C.F.A.
Chief Investment Strategist & Head of Portfolio Strategies
Mr. John W. Geelan
General Counsel & Secretary
Ms. Katherine Patricia Clune
Chief Financial Officer
Mr. Shawn Quant
MD and Chief Information & Operations Officer
Mr. Chad R. Abraham
Chairman & Chief Executive Officer
Mr. James P. Baker
Global Co-Head of Investment Banking & Capital Markets
Mr. Michael Dillahunt
Global Co-Head of Investment Banking & Capital Markets
Ms. Christine N. Esckilsen
Chief Human Capital Officer & MD